Profits were up as the fast-food giant focused on price-conscious customers. But the company said it would cut back on financial support for franchisees.
Doustdar said Medicare coverage and the launch of Novo's new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.
